Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Carrier

Showing results (341-350 of 421) with videos related to

Pageof 43
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 16, 2021
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort studyDavid Aziz, Leslie Skeith, Marc A Rodger, et al.
Blood|May 13, 2020
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysisFrits I Mulder, Floris T M Bosch, Annie M Young, et al.
Journal of Thrombosis and Thrombolysis|May 12, 2024
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register studyMarie Linder, Anders Ekbom, Gunnar Brobert, et al.
Blood Advances|March 17, 2026
Perioperative Management of Antithrombotic Therapy in Patients with Thrombotic Antiphospholipid SyndromeMiguel L Paquette, Sebastien Miranda, Yan Xu, et al.
Blood Advances|June 11, 2026
Effect of PCC on Thrombin Generation in Patients on FXaI with Bleeding or Needing Urgent Surgery (GAUGE)Joseph R Shaw, Hannah Gray, Yan Xu, et al.
Science Translational Medicine|June 17, 2026
Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activationDimitra Karagkouni, Marisa A Brake, Rushad Patell, et al.
Thrombosis Research|June 29, 2010
Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTEM A Rodger, G Le Gal, Marc Carrier, et al.
Thrombosis and Haemostasis|September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort studyEsteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemicDivya Karsanji, James A King, Jenny Godley, et al.
Research and Practice in Thrombosis and Haemostasis|October 22, 2024
Impact of the VTE-PREDICT calculator on clinicians' decision making in fictional patients with venous thromboembolism: a randomized controlled trialDaniël Duijzer, Maria A de Winter, Marc Carrier, et al.
Pageof 43

Showing results (341-350 of 421) with videos related to

Sort By:
Pageof 43
Journal of Thrombosis and Haemostasis : JTH|March 16, 2021
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort studyDavid Aziz, Leslie Skeith, Marc A Rodger, et al.
Blood|May 13, 2020
Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysisFrits I Mulder, Floris T M Bosch, Annie M Young, et al.
Journal of Thrombosis and Thrombolysis|May 12, 2024
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register studyMarie Linder, Anders Ekbom, Gunnar Brobert, et al.
Blood Advances|March 17, 2026
Perioperative Management of Antithrombotic Therapy in Patients with Thrombotic Antiphospholipid SyndromeMiguel L Paquette, Sebastien Miranda, Yan Xu, et al.
Blood Advances|June 11, 2026
Effect of PCC on Thrombin Generation in Patients on FXaI with Bleeding or Needing Urgent Surgery (GAUGE)Joseph R Shaw, Hannah Gray, Yan Xu, et al.
Science Translational Medicine|June 17, 2026
Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activationDimitra Karagkouni, Marisa A Brake, Rushad Patell, et al.
Thrombosis Research|June 29, 2010
Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTEM A Rodger, G Le Gal, Marc Carrier, et al.
Thrombosis and Haemostasis|September 27, 2013
Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort studyEsteban Gándara, Michael J Kovacs, Susan R Kahn, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemicDivya Karsanji, James A King, Jenny Godley, et al.
Research and Practice in Thrombosis and Haemostasis|October 22, 2024
Impact of the VTE-PREDICT calculator on clinicians' decision making in fictional patients with venous thromboembolism: a randomized controlled trialDaniël Duijzer, Maria A de Winter, Marc Carrier, et al.
Pageof 43